Evidence map›Paper›PMID 35145093›Full record

ArticleNature communications2022

Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82.

Stephanie O Erjavec, Sahar Gelfman, Alexa R Abdelaziz, Eunice Y Lee, Isha Monga, Anna Alkelai, Iuliana Ionita-Laza, Lynn Petukhova, Angela M Christiano

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. A scATAC-seq atlas of stasis zone in rat skin burn injury wound process.Frontiers in cell and developmental biology · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Recent advances in the genetics of alopecia areata.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023
    Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Stephanie O Erjavec *Department of Genetics & Development, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0003-4388-3790
Sahar Gelfman *Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Alexa R AbdelazizDepartment of Dermatology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0002-6943-8356
Eunice Y LeeDepartment of Dermatology, Columbia University, New York, NY, USA.
Isha MongaDepartment of Dermatology, Columbia University, New York, NY, USA.
Anna AlkelaiInstitute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Iuliana Ionita-LazaDepartment of Biostatistics, Columbia University, New York, NY, USA.
Lynn PetukhovaDepartment of Dermatology, Columbia University, New York, NY, USA.
Angela M ChristianoDepartment of Genetics & Development, Columbia University, New York, NY, USA. amc65@cumc.columbia.edu.ORCID http://orcid.org/0000-0002-6071-9784
Columbia University · USColumbia University Irving Medical Center · USNutrition 21 (United States) · USRegeneron (United States) · US

Funding

Project 1: Translational Science of Alopecia AreataP50AR070588 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIANO, ANGELA M · 2016 to 2021
$8.0M
Translational and Precision Medicine Resources Core (TRAP)P30AR069632 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI OWENS, DAVID M · 2016 to 2020
$3.9M
Functional Genomics of Alopecia AreataR01AR065963 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIANO, ANGELA M · 2015 to 2018
$2.1M
NIAMS NIH HHS P30 AR069632NIAMS NIH HHS P50 AR070588NIAMS NIH HHS R01 AR065963
6 · The paper itself

Abstract

Alopecia areata is a complex genetic disease that results in hair loss due to the autoimmune-mediated attack of the hair follicle. We previously defined a role for both rare and common variants in our earlier GWAS and linkage studies. Here, we identify rare variants contributing to Alopecia Areata using a whole exome sequencing and gene-level burden analyses approach on 849 Alopecia Areata patients compared to 15,640 controls. KRT82 is identified as an Alopecia Areata risk gene with rare damaging variants in 51 heterozygous Alopecia Areata individuals (6.01%), achieving genome-wide significance (p = 2.18E-07). KRT82 encodes a hair-specific type II keratin that is exclusively expressed in the hair shaft cuticle during anagen phase, and its expression is decreased in Alopecia Areata patient skin and hair follicles. Finally, we find that cases with an identified damaging KRT82 variant and reduced KRT82 expression have elevated perifollicular CD8 infiltrates. In this work, we utilize whole exome sequencing to successfully identify a significant Alopecia Areata disease-relevant gene, KRT82, and reveal a proposed mechanism for rare variant predisposition leading to disrupted hair shaft integrity.

Indexed as

Exome SequencingAlopecia AreataGenetic Predisposition to DiseaseGenetic VariationHairHair FollicleHumansKeratins, Hair-SpecificKeratins, Type IISkinKeratins, Hair-SpecificKeratins, Type IIKRT82 protein, human

Identifiers

PMID35145093
PMCPMC8831607
OpenAlexW4211160591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.